• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
  • Current Cases
  • KSF News
  • Asset Recovery Services
  • Contact KSF

Christopher Tillotson

Home»Attorneys»Christopher Tillotson
Associate
New Orleans Office
(504) 648-0174
christopher.tillotson@ksfcounsel.com
VCARD
 

Christopher Tillotson, an associate in KSF’s Louisiana office, focuses on shareholder M&A litigation and federal securities class action litigation. He is involved in cases pending before courts across the United States.

Mr. Tillotson received his J.D./M.B.A. in 2014 from Washington University in St. Louis, where he focused his studies on the interplay between securities regulations, advanced finance, accounting, and business acquisitions. During his time in law school, Mr. Tillotson served as an associate editor on the Washington University Journal of Law and Policy and earned an Honor Scholar Award for his academic performance. He received his B.A. in Finance from Tulane University in 2009.

Prior to joining KSF, Mr. Tillotson gained valuable experience serving as outside general counsel for several companies headquartered in New York. He also served as an in-house compliance analyst and legal intern for one of the nation’s leading healthcare companies.

Mr. Tillotson is licensed to practice in Louisiana and New York.

Primary Sidebar

KSF News

Delaware Chancery Court Denies Motion to Dismiss Fitbit Inc. Insider Trading Case

Lead Plaintiffs Defeat Motion to Dismiss in Part in Shanawaz v. Intellipharmaceutics International Inc.

Final Judgment of $14.75 Million Entered in Eletrobras Securities Litigation

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice
X

© 2006-2019 Copyright. All rights reserved Kahn Swick & Foti LLC · Louisiana · New York — Kahn Swick & Foti LLP · California